Literature DB >> 25766861

Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort.

Y M Pacheco1, I Jarrin2, I Rosado3, A A Campins4, J Berenguer5, J A Iribarren6, M Rivero7, L Muñoz-Medina8, E Bernal-Morell9, F Gutiérrez10, M Leal3.   

Abstract

The aim was to analyze clinical complications in HIV-infected subjects who persistently maintain low CD4 levels despite virological response to cART in the Spanish CoRIS cohort. The main inclusion criteria were CD4 counts <200cells/mm(3) at cART-initiation and at least 2years under cART achieving a viral load <500copies/mL. Those patients with CD4 counts <250cells/mm(3) 2years after cART were classified as the Low-CD4 group, and clinical events were collected from this time-point. Poisson regression models were used to calculate incidence rate ratios of death, AIDS-defining events, serious non-AIDS-defining events (NAE) and of each specific NAE category (non-AIDS-defining malignancies (non-ADM), cardiovascular, kidney- and liver-related events). Of 9667 patients in the cohort, a total of 1128 met the criteria and 287 (25.4%) were classified in the Low-CD4 group. A higher risk of death (aIRR: 4.71; 95% CI: 1.88-11.82; p-value=0.001) and of non-ADM were observed in this group (aIRR: 2.23; 95% CI: 1.07-4.63; p=0.03). Our results stress the need to control accelerated aging in this population to counter their increased risk of non-AIDS-defining diseases, particularly cancer, and are consistent with the concept that clinical complications are potentially affected by genetics and lifestyle.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AIDS; Clinical complications; Immunodeficiency; Low-CD4 restoration; Mortality; Non-AIDS-defining events; Non-AIDS-defining malignancies

Mesh:

Year:  2015        PMID: 25766861     DOI: 10.1016/j.antiviral.2015.03.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  29 in total

1.  Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer.

Authors:  Nicole L De La Mata; Penh S Ly; Oon T Ng; Kinh V Nguyen; Tuti P Merati; Thuy T Pham; Man P Lee; Jun Y Choi; Annette H Sohn; Matthew G Law; Nagalingeswaran Kumarasamy
Journal:  Int J STD AIDS       Date:  2017-03-21       Impact factor: 1.359

2.  Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease Progression.

Authors:  Sara Ferrando-Martinez; Rebeca S De Pablo-Bernal; Marta De Luna-Romero; Santiago J De Ory; Miguel Genebat; Yolanda M Pacheco; Francisco J Parras; Marta Montero; Jose Ramón Blanco; Felix Gutierrez; Jesus Santos; Francisco Vidal; Richard A Koup; María Ángeles Muñoz-Fernández; Manuel Leal; Ezequiel Ruiz-Mateos
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

Review 3.  Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.

Authors:  Cristina Brickman; Joel M Palefsky
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

4.  The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database.

Authors:  Awachana Jiamsakul; Stephen J Kerr; Ezhilarasi Chandrasekaran; Aizobelle Huelgas; Sineenart Taecharoenkul; Sirinya Teeraananchai; Gang Wan; Penh Sun Ly; Sasisopin Kiertiburanakul; Matthew Law
Journal:  J Clin Epidemiol       Date:  2016-02-04       Impact factor: 6.437

5.  A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.

Authors:  I Rosado-Sánchez; I Herrero-Fernández; A I Álvarez-Ríos; M Genebat; M A Abad-Carrillo; E Ruiz-Mateos; F Pulido; J González-García; M Montero; E Bernal-Morell; F Vidal; M Leal; Y M Pacheco
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.

Authors:  Maria Pino; Susan Pereira Ribeiro; Amélie Pagliuzza; Khader Ghneim; Anum Khan; Emily Ryan; Justin L Harper; Colin T King; Sarah Welbourn; Luca Micci; Sol Aldrete; Keith A Delman; Theron Stuart; Michael Lowe; Jason M Brenchley; Cynthia A Derdeyn; Kirk Easley; Rafick P Sekaly; Nicolas Chomont; Mirko Paiardini; Vincent C Marconi
Journal:  PLoS Pathog       Date:  2021-08-27       Impact factor: 6.823

Review 7.  Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection.

Authors:  Jose D Debes; Paul R Bohjanen; Andre Boonstra
Journal:  J Clin Transl Hepatol       Date:  2016-11-21

8.  A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients.

Authors:  Esther Rodríguez-Gallego; Josep Gómez; Yolanda M Pacheco; Joaquim Peraire; Consuelo Viladés; Raúl Beltrán-Debón; Roger Mallol; Miguel López-Dupla; Sergi Veloso; Verónica Alba; Julià Blanco; Nicolau Cañellas; Anna Rull; Manuel Leal; Xavier Correig; Pere Domingo; Francesc Vidal
Journal:  AIDS       Date:  2018-03-13       Impact factor: 4.177

Review 9.  Residual immune dysfunction under antiretroviral therapy.

Authors:  Catherine W Cai; Irini Sereti
Journal:  Semin Immunol       Date:  2021-03-03       Impact factor: 11.130

10.  Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.

Authors:  Josué Pérez-Santiago; Dan Ouchi; Victor Urrea; Jorge Carrillo; Cecilia Cabrera; Jordi Villà-Freixa; Jordi Puig; Roger Paredes; Eugènia Negredo; Bonaventura Clotet; Marta Massanella; Julià Blanco
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.